###begin article-title 0
###xml 136 140 <span type="species:ncbi:10090">Mice</span>
Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice
###end article-title 0
###begin p 1
Conceived and designed the experiments: JH JA. Performed the experiments: JA ND SB RA SC SV MP. Analyzed the data: JH JA ND. Contributed reagents/materials/analysis tools: DC MF IM MV. Wrote the paper: JH JA.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 106 114 <span type="species:ncbi:9606">children</span>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
In mucopolysaccharidosis type IIIB, a lysosomal storage disease causing early onset mental retardation in children, the production of abnormal oligosaccharidic fragments of heparan sulfate is associated with severe neuropathology and chronic brain inflammation. We addressed causative links between the biochemical, pathological and inflammatory disorders in a mouse model of this disease.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 322 326 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 529 534 <span type="species:ncbi:10090">mouse</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
In cell culture, heparan sulfate oligosaccharides activated microglial cells by signaling through the Toll-like receptor 4 and the adaptor protein MyD88. CD11b positive microglial cells and three-fold increased expression of mRNAs coding for the chemokine MIP1alpha were observed at 10 days in the brain cortex of MPSIIIB mice, but not in MPSIIIB mice deleted for the expression of Toll-like receptor 4 or the adaptor protein MyD88, indicating early priming of microglial cells by heparan sulfate oligosaccharides in the MPSIIIB mouse brain. Whereas the onset of brain inflammation was delayed for several months in doubly mutant versus MPSIIIB mice, the onset of disease markers expression was unchanged, indicating similar progression of the neurodegenerative process in the absence of microglial cell priming by heparan sulfate oligosaccharides. In contrast to younger mice, inflammation in aged MPSIIIB mice was not affected by TLR4/MyD88 deficiency.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
These results indicate priming of microglia by HS oligosaccharides through the TLR4/MyD88 pathway. Although intrinsic to the disease, this phenomenon is not a major determinant of the neurodegenerative process. Inflammation may still contribute to neurodegeneration in late stages of the disease, albeit independent of TLR4/MyD88. The results support the view that neurodegeneration is primarily cell autonomous in this pediatric disease.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 64 67 63 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Bamberger1">[1]</xref>
###xml 122 125 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Zhang1">[2]</xref>
###xml 127 130 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Wilms1">[3]</xref>
###xml 154 156 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sc</sup>
###xml 182 185 177 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Cunningham1">[4]</xref>
###xml 241 244 236 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Moisse1">[5]</xref>
###xml 297 300 292 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Sheng1">[6]</xref>
###xml 344 347 339 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Sapp1">[7]</xref>
###xml 772 775 763 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Block1">[8]</xref>
###xml 777 780 768 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Zipp1">[9]</xref>
###xml 1251 1255 1234 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Etminan1">[10]</xref>
###xml 1257 1261 1240 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Chen1">[11]</xref>
###xml 264 269 <span type="species:ncbi:9606">human</span>
Divergent events such as deposition of Ass in Alzheimer disease [1], alpha-synuclein or neuromelanin in Parkinson disease [2], [3], disease-associated PrPsc protein in prion disease [4], mutants SOD1 protein in amyotrophic lateral sclerosis [5], viral proteins in human immunodeficiency infection [6] or mutant huntingtin in Huntington disease [7] initiate involvement of the immune system, which in turn interacts with the nervous system and set the pace of progressive neurodegeneration. Neurodegenerative diseases are characterized by both local activation of resident microglia and astrocytes and infiltration of leucocytes from the periphery. Immune reaction can be toxic for neurons through the local production of the inflammatory cytokines TNFalpha, IL-1 and IL-6 [8], [9]. Inflammatory chemokines, especially the macrophage inflammatory protein 1alpha (MIP1alpha), are also produced, stimulating microglial activation and attracting peripheral inflammatory cells to the brain parenchyma. Suppressing inflammation is regarded as a potential therapeutic approach against the development of neurodegeneration in AD and PD, especially with regard to the relative protection conferred by the long-term use of non-steroidal anti-inflammatory drugs [10], [11].
###end p 9
###begin p 10
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-WyssCoray1">[12]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Perry1">[13]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Lin1">[14]</xref>
###xml 701 705 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Coleman1">[15]</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Mattson1">[16]</xref>
###xml 853 857 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Rubinsztein1">[17]</xref>
###xml 859 863 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Settembre1">[18]</xref>
###xml 436 441 <span type="species:ncbi:10090">mouse</span>
Whereas the association of chronic neurodegeneration and inflammation is well established, the causative links between these events is debated. Series of evidence from studies performed in animal models of chronic neurodegeneration suggest that microglial activation might be primed by the ongoing pathology rather than the opposite. The deletions of cytokine genes have shown inconsistent, minor or no effect on disease progression in mouse models of neurodegenerative disorders [12], [13]. It is moreover unclear how and to which extent inflammation alone could account for events almost invariably associated with neurodegeneration, such as mitochondrial dysfunction [14], altered axonal transport [15], altered calcium storage and endoplasmic reticulum functions [16], or dysfunction of intracellular protein degradation and macroautophagy pathways [17], [18].
###end p 10
###begin p 11
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Wada1">[19]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Villani1">[25]</xref>
###xml 940 944 936 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Constantopoulos1">[26]</xref>
###xml 946 950 942 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Walkley1">[27]</xref>
###xml 1029 1033 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Li1">[28]</xref>
###xml 1102 1106 1098 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Ryazantsev1">[29]</xref>
###xml 1174 1178 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Li2">[30]</xref>
###xml 1337 1341 1333 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Cressant1">[31]</xref>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 1223 1231 <span type="species:ncbi:9606">children</span>
###xml 1331 1336 <span type="species:ncbi:10090">mouse</span>
###xml 1350 1353 <span type="species:ncbi:9615">dog</span>
Here, we addressed causative links between abnormal metabolite accumulation, brain inflammation and disease marker expression in a mouse model of pediatric neurodegeneration accompanying lysosomal storage diseases. Brain inflammation was documented in several of these diseases [19]-[25]. In mucopolysaccharidosis type III (MPSIII), the unique event responsible for both cell pathology and brain inflammation is the production and accumulation of partially digested, possibly abnormally sulfated or acetylated oligosaccharide fragments of heparan sulfate (HS), a specific type of glycosaminoglycan (GAG). Interruption of HS oligosaccharide degradation is the consequence of a defect in one of the four exoglycanases required for the removal of the alpha-linked N-acetylglucosamine at the non-reducing end of the saccharide chain. The production of HS oligosaccharides is associated to the secondary accumulation of GM2 and GM3 gangliosides [26], [27], to the formation of large cytoplasmic inclusions in various brain cell types [28], to the accumulation of subunit C of the mitochondrial ATP synthase [29], and to the dysregulation of GAP43 mRNA expression in brain tissue [30]. Early onset neurological manifestations in children lead to severe progressive mental retardation and premature death. Our gene therapy studies in the mouse [31] and the dog (M. Ellinwood, J.M. Heard, unpublished) models of MPSIII subtype B (MPSIIIB), a deficiency of alpha-N-acetylglucosaminidase (NaGlu), showed that delivery of the missing enzyme to the brain prevented pathology and clinical manifestations. Here, we provide evidence that microglial cell activation is primed by HS oligosaccharides at very early stage of the disease, although suppression of microglial cell priming by HS oligosaccharides does not modify the course of the neurodegenerative process.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
HS oligosaccharides activate microglial cells
###end title 13
###begin p 14
###xml 198 219 198 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">materials and methods</xref>
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s002">figure S1</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Fuller1">[32]</xref>
###xml 658 665 654 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002296-t001">table 1</xref>
###xml 728 737 724 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s003">figure S2</xref>
###xml 1004 1011 996 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002296-t001">table 1</xref>
###xml 1130 1138 1113 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g001">figure 1</xref>
###xml 1396 1403 1370 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002296-t001">table 1</xref>
###xml 1405 1411 1379 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g001">fig. 1</xref>
###xml 1416 1425 1390 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s003">figure S2</xref>
###xml 1659 1667 1633 1641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g001">figure 1</xref>
###xml 2106 2114 2075 2083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g001">figure 1</xref>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
###xml 339 346 <span type="species:ncbi:9606">patient</span>
###xml 387 391 <span type="species:ncbi:9615">dogs</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
###xml 1301 1307 <span type="species:ncbi:9913">bovine</span>
###xml 1525 1529 <span type="species:ncbi:10090">mice</span>
###xml 1951 1955 <span type="species:ncbi:10090">mice</span>
###xml 2026 2031 <span type="species:ncbi:10090">mouse</span>
We examined whether microglial cell activation could be induced by HS oligosaccharides. For that purpose, HS oligosaccharides were purified from the urines of two MPSIIIB patients (HS1 and HS2, see materials and methods and figure S1). Tandem mass spectrometry analysis identified HS oligosaccharide species previously detected in MPSIIIB patient urines [32] and in the brain of MPSIIIB dogs (M. Fuller, M. Elinwood and J. Hopwood, unpublished). It is therefore presumable that these molecules also accumulate in the brain of MPSIIIB mice. Normal mouse microglia cultures incubated with purified HS oligosaccharides released TNFalpha in culture supernatant (table 1) and showed morphological changes typical of cell activation (figure S2). This phenotype was similar to that induced by LPS. Morphological changes and release of TNFalpha in response to the stimulation by HS oligosaccharides were however not suppressed by polymixin B, a reagent that specifically inhibits LPS and other endotoxin action (table 1). Microglial cell activation induced by HS1 or HS2 led to increased detection of TNFalpha, IL1ss and MIP1alpha mRNAs (figure 1). Compared to LPS, HS oligosaccharides induced lower expression of TNFalpha mRNAs but equivalent levels of IL1ss and MIP1alpha mRNAs. Synthetic heparin, purified bovine HS and GAGs purified from normal individual urine did not activate microglial cultures (table 1, fig. 1 and figure S2). Microglial cell activation was much less intense when microglial cell cultures were derived from mice deficient for the expression of the innate immune response receptor Toll Like Receptor (TLR) 4 or the TLR adaptor protein MyD88 (figure 1). These results indicate that HS oligosaccharides produced by NaGlu deficient organisms stimulated microglial cell activation through the TLR4/MyD88 signaling pathway. Interestingly, higher amounts of IL1ss and MIP1alpha mRNAs were produced by microglial cells isolated from MPSIIIB mice in response to both LPS and HS oligosaccharides compared to wild type mouse microglia, suggesting higher susceptibility to innate immune stimulation (figure 1).
###end p 14
###begin title 15
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Heparan sulfate oligosaccharides activate mouse microglial cells in vitro.
###end title 15
###begin p 16
###xml 95 98 95 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 122 125 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 855 858 820 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 867 870 832 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1132 1136 1088 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Simpson1">[53]</xref>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 244 250 <span type="species:ncbi:9913">bovine</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 523 528 <span type="species:ncbi:10090">mouse</span>
###xml 726 730 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
Microglial cell cultures were established from wild type (white bars), MPSIIIB (red bars), TLR4-/- (yellow bars), or MyD88-/- (green bars) mice. Cells were incubated for 4 hours with normal medium (mock), 5 microg/mL heparin (Hep), 5 microg/mL bovine heparan sulfate (bHS), 5 microg/mL of GAG purified from normal individual urine (nGAG), 1 microg/mL LPS (LPS), 5 microg/mL of heparan sulfate purified from the urines of two MPSIIIB patients (HS1 and HS2) or 10 microg/ml of polyinosine-polycytidylic acid (p[I:C]). Normal mouse microglial activation is shown by increased amounts of TNFalpha, IL-1beta, MIP1alpha mRNA production following incubation with LPS, HS1 or HS2. More robust responses of cells isolated from MPSIIIB mice is consistent with previous in vivo microglial priming, possibly by heparan sulfate. Lower expression by microglia from TLR4-/- or MyD88-/- mice indicates signaling through these molecules, whereas activation persisted upon stimulation by p[I:C], which binds TLR3. Total RNA was extracted, reverse transcribed and amounts of cDNAs coding for TNFalpha, IL-1ss, MIP1alpha, or the reference protein ARPO [53] were measured by Q-PCR. Indicated values are means+/-SEM of ratios of TNFalpha, IL-1ss, MIP1alpha mRNAs to ARPO mRNAs measured in three independent experiments.
###end p 16
###begin title 17
Activated microglial cells release TNFalpha in culture supernatant.
###end title 17
###begin p 18
###xml 60 81 56 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">materials and methods</xref>
TNFalpha was detected in culture supernatants by ELISA (see materials and methods)
###end p 18
###begin p 19
PMB: polymyxin B, a drug that competes with endotoxin binding to TLR4. Absence of inhibition in the presence of PMB suggests that microglial activation was not induced by endotoxins.
###end p 19
###begin p 20
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Values are means+/-SEM from 3 experiments, in which 3 microglial cell cultures were established from different mice.
###end p 20
###begin p 21
###xml 332 335 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 352 355 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 482 490 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g002">figure 2</xref>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
With the aim to examine relationships between microglial cell priming by HS oligosaccharides and the progression of neuroinflammation and neurodegeneration in the brain with age, we studied MPSIIIB mice and produced MPSIIIB mice deficient for the expression of TLR4 or MyD88. As expected, MPSIIIB mice and doubly mutant MPSIIIBxTLR4-/- or MPSIIIBxMyD88-/- mice accumulated equivalent amounts of HS oligosaccharides in the brain, as appreciated by measuring GAGs in tissue extracts (figure 2).
###end p 21
###begin title 22
###xml 39 43 <span type="species:ncbi:10090">mice</span>
GAG accumulate in the brain of MPSIIIB mice.
###end title 22
###begin p 23
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 487 492 <span type="species:ncbi:10090">mouse</span>
Wild type mice (0, white bars), MPSIIIB mice (1, red bars), MPSIIIBxTLR4-/- mice (2, yellow bars), MPSIIIBxMyD88-/- mice (3, green bars), or MPSIIIB mice in which the genetic defect was corrected in the brain by a single intracerebral injection of AAV2.5-hNaGlu vector (4, blue bars) were analyzed at the age of 10 days, 3 months, or 8 months. GAG concentration was determined in cortical tissue extracts. Values are means+/-SEM. Asterisks indicate significant difference with wild type mouse values, crosses indicate significant difference with MPSIIIB values (p<0.05, Mann and Whitney test).
###end p 23
###begin title 24
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Priming of microglial cells is already prominent in the brain of 10-days-old MPSIIIB mice
###end title 24
###begin p 25
###xml 84 93 84 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g003">figure 3A</xref>
###xml 321 330 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g003">figure 3D</xref>
###xml 416 425 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g003">figure 3C</xref>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
###xml 802 806 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
Brain cortical sections were immunostained for CD11b, a marker of microglial cells (figure 3A). Expression of CD11b was more intense in 10-days-old MPSIIIB mice than in age-matched wild type mice. Positive cells showed ramified morphology. IL1ss mRNAs were not expressed at significant level in 10-days-old MPSIIIB mice (figure 3D). However, MIP1alpha mRNA levels were already 3-folds higher than in wild type mice (figure 3C). Increased CD11b staining and MIP1alpha mRNAs expression suggested early priming of microglia in the brain of MPSIIIB. In doubly mutant mice, CD11b expression was lower than in MPSIIIB mice and equivalent to wild type mice. Increased MIP1alpha mRNA expression was not observed in the brain. These results suggest that increased CD11b and MIP1alpha mRNA expression in MPSIIIB mice depended on TLR4 and MyD88. Since HS oligosaccharides are already produced in NaGlu deficient mice at 10 days, this result is consistent with priming of microglial cells by HS oligosaccharides in 10-days-old MPSIIIB mice.
###end p 25
###begin title 26
Microglial cell activation and pathology markers in the brain at 10 days.
###end title 26
###begin p 27
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 759 762 746 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 782 785 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 884 888 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Simpson1">[53]</xref>
###xml 1190 1193 1177 1180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1220 1223 1207 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
###xml 947 951 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
###xml 1144 1148 <span type="species:ncbi:10090">mice</span>
###xml 1165 1169 <span type="species:ncbi:10090">mice</span>
###xml 1194 1198 <span type="species:ncbi:10090">mice</span>
###xml 1224 1228 <span type="species:ncbi:10090">mice</span>
Wild type mice (0, white bars), MPSIIIB mice (1, red bars), MPSIIIBxTLR4-/- mice (2, yellow bars), MPSIIIBxMyD88-/- mice (3, green bars) were analyzed at the age of 10 days. Inflammation markers were studied in cortical samples stained with anti-CD11b antibody (green in A) and by measuring the relative amounts of MIP1alpha (C) and IL1ss (D) mRNAs by quantitative RT-PCR. Disease markers were studied in cortical samples stained with the anti-ScMAS antibody (green in B), and by measuring the relative amounts of GAP43 mRNAs (E) and the accumulation of GM2/GM3 gangliosides (F). Immunofluorescence (A and B): nuclei are stained in blue with Hoescht, scale bars: 20 microm for CD11b, 50 microm for ScMAS. Representative pictures from 3 MPSIIIB, 3 MPSIIIBxTLR4-/- and 3 MPSIIIBxMyD88-/- examined mice. RT-Q-PCR (C, D, E): mRNA amounts are expressed relative to the reference ARPO mRNA [53]. Asterisks indicate significant difference with wild type mice and crosses indicate significant differences with untreated MPSIIIB mice (p<0.05, Mann and Whitney non-parametric test). Number of mice used for GAG, gangliosides and mRNA analyses: wild type mice, n = 6; MPSIIIB mice, n = 6; MPSIIIBxTLR4-/- mice, n = 5; MPSIIIBxMyD88-/- mice, n = 2.
###end p 27
###begin p 28
###xml 78 95 78 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g003">figure 3B and C&#8211;F</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
Mouse brain cortices were examined for altered expression of disease markers (figure 3B and C-F), including GM2 and GM3 ganglioside accumulation, cell vacuolation (not shown), ScMAS immunostaining and GAP43 mRNA expression level. MPSIIIB mice showed reduced expression of GAP43 mRNAs and a mild increased of ScMAS reactivity compared to age-matched wild type mice. Similar reduction of GAP43 mRNA detection and augmentation of ScMAS staining were observed in cortical extracts from doubly mutant mice, indicating that these alterations could take place in the absence of microglial cell priming by HS oligosaccharides.
###end p 28
###begin title 29
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Inflammation was reduced but pathology was severe in doubly mutant mice at 3 months
###end title 29
###begin p 30
###xml 124 133 124 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g004">figure 4A</xref>
###xml 416 428 411 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g004">figure 4C, D</xref>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 458 462 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
CD11b staining was dramatically increased in the brain of MPSIIIB mice at 3 months, compared to age-matched wild type mice (figure 4A). Staining was also more visible in doubly mutant mice than in wild type mice, though much less intense than in MPSIIIB mice. In all cases, CD11b positive cells conserved their ramified morphology. IL1ss and MIP1alpha mRNAs were dramatically increased in 3-months-old MPSIIIB mice (figure 4C, D). In contrast, doubly mutant mice showed normal levels of IL1ss mRNAs and normal or slightly increased levels of MIP1alpha mRNAs. These results show that the development of inflammation in the brain of 3-months-old MPSIIIB mice was primarily the consequence of microglial cell priming involving TLR4 and MyD88.
###end p 30
###begin title 31
Microglial cell activation and pathology markers in the brain at 3 months.
###end title 31
###begin p 32
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1025 1028 1012 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1048 1051 1035 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1141 1145 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Simpson1">[53]</xref>
###xml 1280 1281 1263 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1340 1343 1323 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1363 1366 1346 1349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1523 1532 1506 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s005">figure S4</xref>
###xml 1835 1838 1818 1821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1865 1868 1848 1851 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
###xml 1376 1380 <span type="species:ncbi:10090">mice</span>
###xml 1591 1595 <span type="species:ncbi:10090">mice</span>
###xml 1664 1668 <span type="species:ncbi:10090">mice</span>
###xml 1727 1731 <span type="species:ncbi:10090">mice</span>
###xml 1788 1792 <span type="species:ncbi:10090">mice</span>
###xml 1809 1813 <span type="species:ncbi:10090">mice</span>
###xml 1839 1843 <span type="species:ncbi:10090">mice</span>
###xml 1869 1873 <span type="species:ncbi:10090">mice</span>
###xml 1890 1894 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 1904 1908 <span type="species:ncbi:10090">mice</span>
Wild type mice (0, white bars), MPSIIIB mice (1, red bars), MPSIIIBxTLR4-/- mice (2, yellow bars), MPSIIIBxMyD88-/- mice (3, green bars), or MPSIIIB mice in which the genetic defect was corrected in the brain by a single intracerebral injection of AAV2.5-hNaGlu vector (4, blue bars) were analyzed at the age of 3 months. Inflammation markers were studied in cortical samples stained with anti-CD11b antibody (green in A) and by measuring the relative amounts of MIP1alpha (C) and IL1ss (D) mRNAs by quantitative RT-PCR. Disease markers were studied in cortical samples stained with the anti-ScMAS antibody (green in B), and by measuring the relative amounts of GAP43 mRNAs (E), the accumulation of GM2/GM3 gangliosides (F), and the frequencies of vacuolated neurons or astrocytes (G) and vacuolated microglia in cortical semi-thin sections (H). Immunofluorescence (A and B): nuclei are stained in blue with Hoescht, scale bars: 20 microm for CD11b, 50 microm for ScMAS. Representative pictures from 3 MPSIIIB, 3 MPSIIIBxTLR4-/- and 3 MPSIIIBxMyD88-/- mice. RT-Q-PCR (C, D, E): mRNA amounts are expressed relative to the reference ARPO mRNA [53]. Pathology (G and H): semi-thin sections (1 microm) were stained with toluidin blue. At least 90 neurons/astrocytes were scored per mm2 section surface. Values are from 3 MPSIIIB, 3 MPSIIIBxTLR4-/- and 3 MPSIIIBxMyD88-/- examined mice. Examples of the morphology of cells that were scored as normal neurons or astrocytes, or vacuolated neurons or astrocytes are illustrated in figure S4. Asterisks indicate significant difference with wild type mice and crosses indicate significant differences with untreated MPSIIIB mice (p<0.05, Mann and Whitney non-parametric test). Number of mice used for GAG, gangliosides and mRNA analyses: wild type mice, n = 7; MPSIIIB mice, n = 10; MPSIIIBxTLR4-/- mice, n = 3; MPSIIIBxMyD88-/- mice, n = 3; MPSIIIB+AAV2.5-hNaGlu mice, n = 3.
###end p 32
###begin p 33
###xml 238 246 238 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g002">figure 2</xref>
###xml 388 397 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g004">figure 4A</xref>
###xml 572 583 567 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g004">figure 4C,D</xref>
###xml 897 901 892 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Cressant1">[31]</xref>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
To further document the role of HS oligosaccharide in this response, we treated MPSIIIB mice by gene therapy at the age of 6 weeks. Delivery of the missing enzyme NaGlu in the brain of MSIIIB mice normalized GAG levels in brain extracts (figure 2). CD11b staining in cortical sections was much less intense than in untreated mice, though slightly above levels detected in wild type mice (figure 4A). Detected IL1ss mRNA amounts were also slightly above wild type mouse level, though difference was not significant. MIP1alpha mRNA levels were equivalent to wild type mice (figure 4C,D). These results show that the alteration of inflammation markers in MPSIIIB mice was secondary to GAG accumulation, very low residual expression in treated mice being consistent with very low residual production of HS oligosaccharides, as expected since the therapeutic enzyme is not delivered to all brain cells [31].
###end p 33
###begin p 34
###xml 63 80 63 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g004">figure 4B and E&#8211;H</xref>
###xml 335 344 335 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s005">figure S4</xref>
###xml 457 461 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Li2">[30]</xref>
###xml 595 612 595 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g004">figure 4B and E&#8211;H</xref>
###xml 786 803 786 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g004">figure 4B and E&#8211;H</xref>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 780 784 <span type="species:ncbi:10090">mice</span>
All disease markers were affected in MPSIIIB mice at 3 months (figure 4B and E-H). GM2 and GM3 ganglioside levels were higher than in age-matched wild type mice. Large cytoplasmic inclusions were visible in various cell types including neurons, astrocytes, microglia, endothelial, epithelial and meningeal cells (examples are shown in figure S4). Immunostaining for ScMAS was increased. GAP43 mRNA levels were low compared to wild type, as previously shown [30]. Enzyme delivery by gene therapy and prevention of GAG accumulation was associated with a complete normalization of disease markers (figure 4B and E-H), indicating that toxic effects on brain cells were secondary to HS oligosaccharide accumulation. Disease markers were similarly detected in MPSIIIB and doubly mutant mice (figure 4B and E-H), indicating that neurodegeneration was not delayed when inflammation markers were absent or expressed at low level. Therefore, disease development at 3 months was mostly independent of microglial cell priming through TLR4 and MyD88.
###end p 34
###begin title 35
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Inflammation and pathology were severe in MPSIIIB and doubly mutant mice at 8 months
###end title 35
###begin p 36
###xml 71 84 71 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g005">figure 5A,C,D</xref>
###xml 319 328 319 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s004">figure S3</xref>
###xml 493 506 488 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g005">figure 5A,C,D</xref>
###xml 678 690 668 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g005">figure 5 C,D</xref>
###xml 717 726 707 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g005">figure 5A</xref>
###xml 777 790 767 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g005">figure 5A,C,D</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
Eight-months-old MPSIIIB mice showed severe inflammation in the brain (figure 5A,C,D). CD11b staining was intense and associated to astrocytosis, as shown by increased reactivity for glial fibrillary acidic protein (GFAP), a marker of astrocytes (astrocytosis was not detected at 10 days and was very mild at 3 months, figure S3). Amounts of IL1ss and MIP1alpha mRNAs were high. Although slightly milder than in MPSIIIB mice, inflammation was also intense in the cortex of doubly mutant mice (figure 5A,C,D), suggesting it was mostly independent of TLR4 and MyD88 at this stage, in contrast to the observations made at 3 months. However, the disappearance (IL1ss and MIP1alpha, figure 5 C,D) or the reduction (CD11b, figure 5A) of inflammatory markers in treated MPSIIIB mice (figure 5A,C,D) indicated that the inflammatory reaction was nevertheless triggered by HS oligosaccharides, although presumably through different mechanisms in aged mice than in younger animals.
###end p 36
###begin title 37
Microglial cell activation and pathology markers in the brain at 8 months.
###end title 37
###begin p 38
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 115 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 994 997 981 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1017 1020 1004 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1110 1114 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Simpson1">[53]</xref>
###xml 1249 1250 1232 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1309 1312 1292 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1332 1335 1315 1318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1492 1501 1475 1484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s005">figure S4</xref>
###xml 1804 1807 1787 1790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1834 1837 1817 1820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 1021 1025 <span type="species:ncbi:10090">mice</span>
###xml 1345 1349 <span type="species:ncbi:10090">mice</span>
###xml 1560 1564 <span type="species:ncbi:10090">mice</span>
###xml 1633 1637 <span type="species:ncbi:10090">mice</span>
###xml 1696 1700 <span type="species:ncbi:10090">mice</span>
###xml 1757 1761 <span type="species:ncbi:10090">mice</span>
###xml 1778 1782 <span type="species:ncbi:10090">mice</span>
###xml 1808 1812 <span type="species:ncbi:10090">mice</span>
###xml 1838 1842 <span type="species:ncbi:10090">mice</span>
###xml 1859 1863 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 1873 1877 <span type="species:ncbi:10090">mice</span>
Wild type mice (0, white bars), MPSIIIB mice (1, red bars), MPSIIIBxTLR4-/- mice (2, yellow bars), MPSIIIBxMyD88-/- mice (3, green bars), or MPSIIIB mice in which the genetic defect was corrected in the brain by a single intracerebral injection of AAV2.5-hNaGlu vector (4, blue bars) were analyzed at the age of 8 months. Inflammation markers were studied in cortical samples stained with anti-CD11b antibody (green in A) and by measuring the relative amounts of MIP1alpha (C) and IL1ss (D) mRNAs by quantitative RT-PCR. Disease markers were studied in cortical samples stained with the anti-ScMAS antibody (green in B), and by measuring the relative amounts of GAP43 mRNAs (E), the accumulation of GM2/GM3 gangliosides (F), and the frequencies of vacuolated neurons or astrocytes (G) and vacuolated microglia (H). Immunofluorescence (A and B): nuclei are stained in blue with Hoescht, scale bars: 20 microm for CD11b, 50 microm for ScMAS. Representative pictures from 3 MPSIIIB, 3 MPSIIIBxTLR4-/- and 3 MPSIIIBxMyD88-/- mice. RT-Q-PCR (C, D, E): mRNA amounts are expressed relative to the reference ARPO mRNA [53]. Pathology (G and H): semi-thin sections (1 microm) were stained with toluidin blue. At least 90 neurons/astrocytes were scored per mm2 section surface. Values are from 3 MPSIIIB, 3 MPSIIIBxTLR4-/- and 3 MPSIIIBxMyD88-/- examined mice. Examples of the morphology of cells that were scored as normal neurons or astrocytes, or vacuolated neurons or astrocytes are illustrated in figure S4. Asterisks indicate significant difference with wild type mice and crosses indicate significant differences with untreated MPSIIIB mice (p<0.05, Mann and Whitney non-parametric test). Number of mice used for GAG, gangliosides and mRNA analyses: wild type mice, n = 5; MPSIIIB mice, n = 10; MPSIIIBxTLR4-/- mice, n = 4; MPSIIIBxMyD88-/- mice, n = 1; MPSIIIB+AAV2.5-hNaGlu mice, n = 3.
###end p 38
###begin p 39
###xml 103 120 103 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g005">figure 5B and E&#8211;H</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Li2">[30]</xref>
###xml 526 543 526 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g005">figure 5B and E&#8211;H</xref>
###xml 643 660 643 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002296-g005">figure 5B and E&#8211;H</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
As expected, disease markers were more severely affected in MPSIIIB mice at 8 months than at 3 months (figure 5B and E-H): GM2 and GM3 ganglioside levels were higher, cell vacuolation was more prominent and ScMAS immunostaining was more intense. GAP43 mRNA levels, which decrease with age in wild type mice, at the opposite increased in MPSIIIB mice, switching from abnormally low levels in young mice to abnormally high levels in aged mice, as previously described [30]. Similar features were observed in doubly mutant mice (figure 5B and E-H), whereas 8-months-old mice that received gene therapy were similar to age-matched wild type mice (figure 5B and E-H). This observation confirmed that the toxic effects of HS oligosaccharides on the brain of ageing mice were mostly independent of microglial cell priming through TLR4 and MyD88.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 1410 1414 1410 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Jeyakumar1">[20]</xref>
###xml 1472 1476 1472 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Jou1">[33]</xref>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 1305 1309 <span type="species:ncbi:10090">mice</span>
###xml 1374 1378 <span type="species:ncbi:10090">mice</span>
In MPSIII, neuroinflammation and neuropathology are caused by the production and accumulation of HS oligosaccharides that are absent in normal cells. The aim of the present study was to examine causative links between HS oligosaccharide accumulation, inflammation and disease markers in the cortex of MPSIIIB mice. Our approach associated microglial cell cultures, modulation of brain inflammation in cross-bred mice and disease correction by gene therapy. Results provided evidence that HS oligosaccharides primed microglial activation through TLR4 and MyD88 both in vitro and in the MPSIIIB mouse brain. However, suppression of microglial priming in MPSIIIB mice deleted for TLR4 and MyD88 showed dissociation between inflammation, which was absent or drastically reduced in young animals (10 days and 3 months), and expression of disease markers, which was unchanged. We conclude that neurodegeneration progresses independently of the stimulation of the innate response by HS. Nevertheless, injuries subsequent to the degenerative process progressively created a chronic inflammatory state in the brain of ageing MPSIIIB mice (8 months), which was independent of TLR4 and MyD88, and which in turn may have exacerbated pathology. Injuries that possibly stimulated chronic inflammation in ageing MPSIIIB mice are the alteration of the blood-brain barrier, as documented in mice with GM1 or GM2 gangliosidosis [20], the secondary accumulation of GM2 and GM3 ganglisosides [33] and the cell death.
###end p 41
###begin p 42
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Johnson1">[34]</xref>
Microglial activation by HS oligosaccharides is consistent with a previous report showing that these molecules activate dendritic cells through TLR4 [34]. Our experimental controls indicated that only HS oligosaccharides, and not non-fragmented HS or chondroitin sulfate activated microglia in vitro. HS oligosaccharide fragments are produced in early endosomes by heparinases and thereafter transferred to lysosomes for further digestion by exoglycanases. The size of abnormal undigested oligosaccharides accumulating in exoglycanase deficient cells, such as oligosaccharides with terminal alpha-linked N-acetylglucosamine in MPSIIIB, ranges from single to multiple repeats of disaccharides. Further studies will specify the structure, sulfation and acetylation of HS oligosaccharide species responsible for priming microglial activation.
###end p 42
###begin p 43
###xml 877 881 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Zhou1">[35]</xref>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
In vitro assays showed a moderate effect of HS oligosaccharides with respect to TNFalpha mRNA production and a much more robust effect on MIP1alpha and IL1beta mRNA expression. We therefore focused in vivo studies on the latter two factors. They are principally produced in the brain by activated microglia and/or astrocytes. In 10-days-old MPSIIIB mice, we observed increased CD11b staining and normal GFAP staining, suggesting that MIP1alpha and IL1beta mRNAs were produced by activated microglia. Although GAG concentration in brain extracts was still in the normal range at this stage, abnormal HS oligosaccharides were already produced because of the enzyme defect, and therefore possibly triggered microglial cell priming. Other stimuli that could trigger microglial cell priming, like cell vacuolation and death and/or secondary accumulation of GM2 and GM3 gangliosides [35], were absent at this stage. Consistently with the stimulation of microglial cell priming by HS oligosaccharides in the brain, deletion of the innate immune response mediators TLR4 or MyD88 in MPSIIIB mice showed substantial reduction of CD11b staining and of the expression level of IL1beta and MIP1alpha mRNAs at 10 days and 3 months, as observed in vitro.
###end p 43
###begin p 44
###xml 172 176 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Wu1">[36]</xref>
###xml 301 305 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Tsuji1">[37]</xref>
###xml 476 480 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Jeyakumar1">[20]</xref>
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
Early MIP1alpha production in the MPSIIIB mouse brain is reminiscent of the implication of this chemokine in the neurodegenerative process associated with Sandhoff disease [36]. Possibly, oligosaccharides with terminal ss-linked N-acetylglucosamine could prime microglia in this disease, as suggested [37]. Microglial activation and increased MIP1alpha gene expression were also observed in the mouse models of GM1 and GM2 gangliosidoses before the onset of neurodegeneration [20].
###end p 44
###begin p 45
###xml 543 547 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Constantopoulos1">[26]</xref>
###xml 549 553 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Ryazantsev1">[29]</xref>
###xml 555 559 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Li2">[30]</xref>
###xml 561 565 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Neufeld1">[38]</xref>
###xml 737 741 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Villani1">[25]</xref>
###xml 743 747 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Li2">[30]</xref>
###xml 749 753 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Heldermon1">[39]</xref>
###xml 850 854 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Li1">[28]</xref>
###xml 856 860 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Cressant1">[31]</xref>
###xml 862 866 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Heldermon1">[39]</xref>
###xml 1104 1108 1095 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Wu1">[36]</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
###xml 1025 1029 <span type="species:ncbi:10090">mice</span>
###xml 1247 1251 <span type="species:ncbi:10090">mice</span>
###xml 1309 1313 <span type="species:ncbi:10090">mice</span>
An important observation in doubly mutant mice versus MPSIIIB mice was the dissociation at 10 days, and more clearly at 3 months, between the reduced expression of inflammation markers and the severe expression of disease markers. Less intense CD11b staining and reduced amounts of MIP1alpha and IL1ss mRNAs were not associated with delayed occurrence of cell vacuolation, ganglioside accumulation, detection of ScMAS or altered expression of GAP43 mRNAs, which are relevant markers of the progression of the neurodegenerative process in MPSs [26], [29], [30], [38]. Other markers were not investigated in doubly mutant mice. They include brain cell apoptosis and Purkinje cell loss, which were not consistently observed in MPSIIIB mice [25], [30], [39]. The study of behavioral manifestations, which led to controversial conclusions in MPSIIIB mice [28], [31], [39], and that of the mean life-span were not performed because of the limited number of available doubly mutant mice. Investigations of these markers in Sandhoff mice showed delayed occurrence when affected animals did not express MIP1alpha [36]. It remains to be established whether the apparently different impact of priming of the innate immune response in Sandhoff and MPSIIIB in mice is due to difference in the courses of these diseases in mice, difference in the mechanisms leading to brain inflammation, difference in the invalidated innate immune response genes, or difference in the investigated disease markers.
###end p 45
###begin p 46
###xml 813 815 812 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sc</sup>
###xml 875 879 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Perry1">[13]</xref>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
###xml 1097 1102 <span type="species:ncbi:10090">mouse</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1240 1248 <span type="species:ncbi:9606">children</span>
In MPSIIIB mice that received AAV vector mediated gene therapy directed to the brain, microglial activation had been primed by HS oligosaccharides before treatment. The clearance of HS oligosaccharides after treatment was associated with the absence of expression of disease markers and the very low, though often still detectable expression of some inflammation markers, including slightly increased CD11b signals and IL1ss mRNA amounts. It is conceivable that trace amounts of residual HS oligosaccharides production at locations in the brain where enzyme delivery was less efficient led to persisting chronic stimulation of the innate immune response. As a consequence, these mice may be more susceptible to additional stimulation, as proposed for prion disease in which priming of microglial activation by Prpsc exacerbated innate immune responses to microbial pathogens [13]. This hypothesis is supported by the observation that microglial cells isolated from MPSIIIB mice produced higher amounts of MIP1alpha and IL1ss mRNAs in vitro in response to LPS or HS oligosaccharides than wild type mouse microglia. A further investigation of this issue in MPSIIIB mice is worthwhile, since it may be relevant to the outcome of treatments in children.
###end p 46
###begin p 47
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Stagi1">[40]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Takeuchi1">[41]</xref>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 874 878 <span type="species:ncbi:10090">mice</span>
###xml 1102 1106 <span type="species:ncbi:10090">mice</span>
Our results indicate that inflammation may have different causes and consequences depending on disease progression in the brain of MPSIIIB mice. Priming of microglial activation by HS oligosaccharides occurs at very early stage of the disease, whereas pathology is still very mild. Activated microglia are thought to act as effector cells in the degeneration of neural cells in the central nervous system. Soluble factors released by activated microglia are capable of inducing intracellular swelled vesicles (beads) in neuron dendrites and axons [40], [41]. However, although this mechanism might be relevant to the development of vacuolation and ScMAS accumulation in MPSIIIB neuron, it is presumably not involved in MPSIIIB since the appearance of these disease markers was not delayed when microglial activation by HS oligosaccharides was reduced in young doubly mutant mice. It is therefore likely that at early stage of the disease pathology developing in the MPSIIIB central nervous system is cell-autonomous rather than environmental. Observation made in 8-months-old MPSIIIB and doubly mutant mice suggest that the situation may be different at later stage of the disease, when additional stimuli of innate immunity subsequent to pathology development are likely predominant. Responses to these stimuli is independent of TLR4 and MyD88 but may be exacerbated by the permanent stimulation of microglia by HS oligosaccharides. They presumably induce a self-sustained chronic inflammation that is potentially harmful to the central nervous system.
###end p 47
###begin title 48
Materials and Methods
###end title 48
###begin title 49
Reagents
###end title 49
###begin p 50
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Limulus</italic>
###xml 13 17 <span type="species:ncbi:9913">calf</span>
###xml 115 131 <span type="species:ncbi:562">Escherichia coli</span>
###xml 142 148 <span type="species:ncbi:9913">bovine</span>
Media, fetal calf serum and antibiotics were from Invitrogen (Carlsbad, California). Lipopolysaccharide (LPS, from Escherichia coli 0111:B4), bovine HS (Heparin monosulfate sodium-potassium salt), desulfated heparin (partially acetylated; semi-synthetic), Polymyxin B, E-Toxate kit (Limulus Amebocyte Lysate, LAL) were from Sigma (St Louis, MO, USA). Polyinosine-polycytidylic acid (poly[I:C]) was from InvivoGen (Toulouse, France).
###end p 50
###begin title 51
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients, urine collection, HS oligosaccharide purification, microglia cultures
###end title 51
###begin p 52
###xml 2 9 <span type="species:ncbi:9606">Patient</span>
###xml 45 52 <span type="species:ncbi:9606">patient</span>
- Patient 1 (11-years-old, GAG1 and HS1) and patient 2 (8-years-old, GAG2 and HS2) were diagnosed for MPSIIIB before the age of 5 years. Both had severe neurological manifestations at the time of urine collection. Urines were collected under sterile conditions and immediately stored at -20degreesC. According to the French law (Code de la Sante Publique, art. L1121-1), urine collection without diagnostic or prospective investigation purpose is not considered as Biomedical Research and therefore does not require ethical committee approval.
###end p 52
###begin p 53
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Piraud1">[42]</xref>
###xml 61 68 <span type="species:ncbi:9606">patient</span>
- Isolation and characterization of HS oligosaccharides from patient urine. GAGs were isolated as previously described [42]. Urines were acidified to pH 5.0-6.0 with acetic acid and centrifuged. Cetylpyridinium chloride (CPC, 200 microL 5% w/v) was added to supernatants for 12 hours at 4degreesC and centrifuged. Pellets were successively washed with ethanol saturated with sodium chloride, ethanol and ether, dried and resuspended in 0.6 mol/L NaCl at 4degreesC for 3 hours. After centrifugation, supernatants with solubilized GAGs were precipitated with ethanol at 4degreesC for 12 hours. Pellets were washed as before, resuspended in water and used as GAG fraction.
###end p 53
###begin p 54
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Masuda1">[43]</xref>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Piraud1">[42]</xref>
###xml 769 776 763 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Limulus</italic>
###xml 1006 1010 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Fuller1">[32]</xref>
- Isolation of HS from the GAG fraction was performed as previously described [43]. GAG pellets were dissolved in 0.25 M NaCl and applied on a Dowex 1x2 column (100-200 mesh, Cl- form) previously equilibrated with 0.25 M NaCl. After washing with 0.25 M NaCl, stepwise elution of HS was performed with 0.5 M, 0.75 M, 1 M and 1.25 M NaCl. Fractions were assayed for uronic acid content by hexuronic acid measurement [42] and analyzed by cellulose acetate electrophoresis. Fractions containing HS were pooled and precipitated with 4 volumes of ethanol at 4degreesC for 12 h. After centrifugation, pellets were dried, resuspended in water and used as HS fraction. Preparations used for microglia activation assays were free of detectable endotoxin contaminant, as shown by Limulus Amebocyte Lysate (LAL) assays. Oligosaccharides in HS fractions were derivatised with 1-phenyl-3-methyl-5-pyrazolone and analysed by ESI-MS/MS using a PE Sciex API 3000 triple quadrupole mass spectrometer as described previously [32].
###end p 54
###begin p 55
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Hoshino1">[44]</xref>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Adachi1">[45]</xref>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Qin1">[46]</xref>
###xml 820 821 812 813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 897 898 883 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1175 1176 1161 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1386 1387 1354 1355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 366 372 <span type="species:ncbi:10090">murine</span>
- Microglia cultures. Three day-old C57BL/6J mice were obtained from Janvier Inc. (Le Genest-St-Isle, France). TLR4 deficient [44] and MyD88 deficient [45] C57BL/6J mice were obtained from the laboratory of Shizuo Akira, backcrossed eight times to the C57Bl/6 background and bred in the central animal facility of the Pasteur Institute under SPF conditions. Primary murine microglia cultures were prepared as previously described [46]. Briefly, cerebral cortices without meninges were mechanically and enzymatically dissociated with proteinase (10 U/mL) and DNase (4000 U/mL). After adding of DMEM supplemented with 10% endotoxin free heat-inactivated FBS and 50 microg/mL gentamycin, cells were plated in DMEM 10% FCS on 100 mm Petri dishes coated with 1.5 microg/mL poly-DL-ornithine (3 to 15 kDa) at a density of 3x106 cells/dishes. Mixed glial cultures were maintained at 37degreesC with 5% CO2 and medium was changed after 4 days. After 12 days, dishes were shaken at 150 rpm for 90 min to detach non-adherent microglia. Detached cells were collected and plated on either 24-well tissue culture plate slides or in 6-well tissue plates at a density of 67,500 cells per cm2 and maintained at 37degreesC for 1 hour. After one hour at 37degreesC, loosely adherent contaminating oligodendrocytes were removed from the cultures. Adherent microglia was maintained at 37degreesC with 5% CO2 for one day before treatment. Culture supernatants or total RNAs were harvested at the indicated time after treatment and stored at -80degreesC until assayed. Polymyxin B (10 microg/mL) was added to cultures one hour before treatment with inducer.
###end p 55
###begin p 56
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 73 76 <span type="species:ncbi:10116">rat</span>
###xml 152 155 <span type="species:ncbi:10116">rat</span>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
###xml 456 462 <span type="species:ncbi:9913">bovine</span>
###xml 495 499 <span type="species:ncbi:9925">goat</span>
###xml 548 552 <span type="species:ncbi:9925">goat</span>
- Immuofluorescence assays on microglia cultures. Antibodies: mouse anti-rat ED1 monoclonal antibody (mAb, 1:200, clone OBT1150, Immunological direct), rat anti-mouse CD11b mAb (1:500, clone M1/70, BD Biosciences). Microglia seeded onto 15 microg/mL poly-DL-ornithine round coverslips was washed in PBS and fixed with 4% paraformaldehyde for 15 minutes. After 3 washes with PBS, cells were incubated overnight at 4degreesC with primary antibody in PBS, 1% bovine serum albumine (BSA), 2% normal goat serum (anti-CD11b) or in PBS, 1% BSA, 2% normal goat serum, 0.3% Triton (anti-ED1, anti-CD68, anti-GFAP). Bound antibodies were revealed by one-hour incubation at room temperature with Alexa Fluor 488 or 545-conjugated antibodies (1:500, Invitrogen) and 1 microg/mL DAPI. Coverslips were mounted in Fluoromount-G (Southern Biotech, Birmingham, AL). Observations were done on Axioplan 2 imaging optic microscope (Zeiss, Le Pecq, France).
###end p 56
###begin p 57
###xml 2 7 <span type="species:ncbi:10090">Mouse</span>
- Mouse TNF-alpha ELISA was from Biosource International (Camarillo, CA, USA). Sensitivity was 10 pg/mL.
###end p 57
###begin title 58
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice, gene transfer to the brain, tissue processing and analysis
###end title 58
###begin p 59
###xml 216 224 216 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NaGlu+/&#8722;</sup>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Li1">[28]</xref>
###xml 309 316 309 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4&#8722;/&#8722;</sup>
###xml 316 320 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Hoshino1">[44]</xref>
###xml 332 340 332 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MyD88&#8722;/&#8722;</sup>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Adachi1">[45]</xref>
###xml 408 424 408 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NaGlu&#8722;/&#8722;,TLR4&#8722;/&#8722;</sup>
###xml 436 453 436 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NaGlu&#8722;/&#8722;,MyD88&#8722;/&#8722;</sup>
###xml 488 504 488 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NaGlu+/&#8722;,TLR4+/&#8722;</sup>
###xml 515 532 515 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NaGlu+/&#8722;,MyD88+/&#8722;</sup>
###xml 720 728 720 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s001">table S1</xref>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Cressant1">[31]</xref>
###xml 2 7 <span type="species:ncbi:10090">Mouse</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 562 566 <span type="species:ncbi:10090">mice</span>
- Mouse experiments were approved by the Institut Pasteur ethical committee for animal research and performed by authorized investigators (authorization no. 75-268, Ministere de l'Agriculture et de la Peche). C57Bl/6NaGlu+/- MPSIIIB mice were obtained from Pr. E. Neufeld (UCLA, Los Angeles, CA) [28]. C57Bl/6TLR4-/-[44] and C57Bl/6MyD88-/-[45] mice were obtained from the laboratory of Shizuo Akira. C57Bl/6NaGlu-/-,TLR4-/- and C57Bl/6NaGlu-/-,MyD88-/- were generated by breeding C57Bl/6NaGlu+/-,TLR4+/- or C57Bl/6NaGlu+/-,MyD88+/-, respectively. Doubly mutant mice were identified by genotyping. They were sterile and could not be propagated. Absence of NaGlu, TLR4 or MyD88 expression was verified in brain extracts (table S1). Correction of the genetic defect and phenotype in the brain was performed as described [31], using AAV vectors coding for the missing enzyme NaGlu.
###end p 59
###begin p 60
###xml 225 251 221 247 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGTCAGCCTGTGCTATGAG-3&#8242;</named-content>
###xml 262 288 258 284 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGTACCCAGCAAGAAGTGG-3&#8242;</named-content>
###xml 317 350 313 346 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTTGCCCTTCAGTCACAGAGACTCTG-3&#8242;</named-content>
###xml 361 394 357 390 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGTGTAAACCAGCCAGGTTTTGAAGGC-3&#8242;</named-content>
###xml 424 457 420 453 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCCTCTACACCCTTCTCTTCTCCACA-3&#8242;</named-content>
###xml 468 501 464 497 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGACAGGCTGAGTGCAAACTTGTGCTG-3&#8242;</named-content>
###xml 602 632 594 624 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGAGGCTATTCGGCTATGACTG-3&#8242;</named-content>
###xml 643 673 635 665 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGACAGGTCGGTCTTGACAAAAAG-3&#8242;</named-content>
###xml 702 735 694 727 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTTGCCCTTCAGTCACAGAGACTCTG-3&#8242;</named-content>
###xml 746 779 738 771 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATCGCCTTCTATCGCCTTCTTGACGAG-3&#8242;</named-content>
###xml 809 842 801 834 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGCCTCTACACCCTTCTCTTCTCCACA-3&#8242;</named-content>
###xml 853 886 845 878 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATCGCCTTCTATCGCCTTCTTGACGAG-3&#8242;</named-content>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
- Selection of single and doubly mutant mice. Genotype at NaGlu, TLR4 and MyD88 loci was determined by PCR, using tail DNA. Primers used for the detection of wild type alleles: alpha-N-acetylglucosamine gene exon 6: forward: 5'-TGGTCAGCCTGTGCTATGAG-3'; reverse: 5'-AGGTACCCAGCAAGAAGTGG-3'. TLR4 gene exon 3: forward: 5'-TGTTGCCCTTCAGTCACAGAGACTCTG-3'; reverse: 5'-CGTGTAAACCAGCCAGGTTTTGAAGGC-3'. MyD88 gene exon 4: forward: 5'-AGCCTCTACACCCTTCTCTTCTCCACA-3'; reverse: 5'-AGACAGGCTGAGTGCAAACTTGTGCTG-3'. Primers used for the detection of mutated alleles: alpha-N-acetylglucosamine gene exon 6: forward: 5'-GGAGAGGCTATTCGGCTATGACTG-3', reverse: 5'-GGACAGGTCGGTCTTGACAAAAAG-3'; TLR4 gene exon 3: forward: 5'-TGTTGCCCTTCAGTCACAGAGACTCTG-3', reverse: 5'-ATCGCCTTCTATCGCCTTCTTGACGAG-3'; MyD88 gene exon 4: Forward: 5'-AGCCTCTACACCCTTCTCTTCTCCACA-3', reverse: 5'-ATCGCCTTCTATCGCCTTCTTGACGAG-3'
###end p 60
###begin p 61
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 150 153 150 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 305 308 305 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 329 332 329 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 342 345 342 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 675 683 675 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002296.s001">table S1</xref>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Zhao1">[47]</xref>
###xml 1344 1346 1344 1346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1349 1351 1349 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1380 1384 1380 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Salvetti1">[48]</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:10090">mice</span>
###xml 687 709 <span type="species:ncbi:272636">Adeno-associated virus</span>
###xml 744 748 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 858 862 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 940 944 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 950 955 <span type="species:ncbi:10090">mouse</span>
###xml 1008 1013 <span type="species:ncbi:9606">human</span>
- Breeding procedures. MPSIIIB (NaGlu-/-) were produced by crossing NaGlu+/- mice and selection of the progeny on genotype. Breeding of NaGlu-/-xNaGlu-/- was possible, though poorly efficient. NaGlu-/-xTLR4-/- and NaGlu-/-xMyD88-/- were produced by selection of the progeny of cross-breeding between NaGlu-/- and TLR4-/- or NaGlu-/- and Myd88-/-. Doubly mutant mice were sterile. All experiments involving doubly mutant mice were therefore performed on F1 mice. The absence of NaGlu activity was verified by enzyme assay in brain extracts. The absence of detection of TLR4 or MyD88 was verified by quantitative RT-PCR in brain extracts and by western blot in liver extracts (table S1).- Adeno-associated virus vector and vector production. The AAV2.5-hNaGlu vector is a hybrid AAV vector in which the capsid is from the AAV5 serotype and the genome from the AAV2 serotype. The vector genome contains the Inverted Terminal Repeats (ITRs) of AAV2, the mouse phosphoglycerate kinase-1 gene promotor (mPGK), the human NaGlu cDNA [47] and the BGH polyadenylation sequence. A control AAV vector was similarly constructed except that mPGK promoter sequences were deleted. Vector batches were produced by transient transfection of HEK293 cells and purified using two successive CsCl gradients. Purified fractions were pooled and dialysed against PBS/Ca2+/Mg2+ (Biowhitaker), as described [48]. Vector genomes (vg) were quantified by dot blot.
###end p 61
###begin p 62
###xml 47 50 47 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 329 330 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 277 281 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
- Intracranial injections. Six-week-old MPSIIIB-/- mice were anesthetized with ketamine/xylazine (0.1/0.01 mg/g body weight) and installed on a stereotactic frame (David Kopf Instruments, Tujunga, CA) (n = 9). The skull was exposed by a small incision. Five microliters of the AAV2.5-hNaGlu vector or the control AAV vector (3x109 vg) were injected into the striatum with a Hamilton syringe with a 30-gauge blunt tip needle mounted to the stereotactic frame (coordonates +0.7 mm anterior to bregma, 2 mm left lateral to the midline and 4.5 mm depth). 2.5 microl of vector was delivered with an ultramicropump (World Precision Instruments, Hertfordshire, UK) at a rate of 500 nl/min. The needle was then brought up 0.5 mm and the rest of the volume was injected at the same rate. The needle was slowly withdrawn, the scalp was closed and the animals were returned to recovery cages.
###end p 62
###begin p 63
###xml 27 73 27 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mice that did not receive AAV vector injection</italic>
###xml 338 339 338 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 927 966 903 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mice that received AAV vector injection</italic>
###xml 27 31 <span type="species:ncbi:10090">Mice</span>
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
###xml 927 931 <span type="species:ncbi:10090">Mice</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
###xml 1002 1006 <span type="species:ncbi:10804?0.6129032258064516">AAV2</span>
###xml 1030 1034 <span type="species:ncbi:10090">mice</span>
###xml 1106 1110 <span type="species:ncbi:10090">mice</span>
###xml 1150 1154 <span type="species:ncbi:10090">mice</span>
- Brain tissue processing. Mice that did not receive AAV vector injection: biochemistry, RT-PCR and imaging studies were all performed in the same mouse. After perfusion with PBS, brains were removed and hemispheres were separated. The right hemisphere was collected for GAG assay. The left hemisphere was sliced. Cortical fragments (3 mm3) were collected for RT-PCR analysis, immunofluorescence analysis and semi-thin sections. Fragments for RT-PCR were immediately frozen in nitrogen and stored at -135degreesC until RNA extraction. Fragments for immunofluorescence were fixed with 4% paraformaldehyde (PFA) for 1 hour at +4degreesC, rinsed, immersed in 30% sucrose and embedded in O.C.T. (Tissue-tek, Sakura) and stored at -80degreesC until cryosection. Fragments for semi-thin sections were fixed by immersion with 3.6% glutaraldehyde at +4degreesC, post-fixed in 2% aqueous osmium tetroxide and embedded in epon-araldite. Mice that received AAV vector injection: treated MPSIIIB mice received the AAV2.5-hNaGlu vector. These mice were used for either biochemical or pathology analyses. Control normal mice received the control AAV vector. These mice were used for biochemical analyses, providing information about inflammatory response to AAV vector particle injection in the brain. Biochemical analyses were performed using cortical fragments collected from the injected hemisphere and immediately frozen in nitrogen for RT-QT-PCR analysis. They included enzyme activities and GAG assay. Pathology analyses were performed after intracardial perfusion with 4% PFA. Brains were removed, hemispheres were separated and cortical fragments were collected. They were used for immunofluorescence and semi-thin sections, as described below.
###end p 63
###begin p 64
- Semi-thin sections. One-micrometer-thick sections were prepared, stained with toluidine blue for 2 hours and examined with a bright field microscope (Axiovision software, Carl Zeiss, MicroImaging, Inc.). Images were acquired with a 100x objective lens from 5 randomly chosen areas of the cerebral cortex.
###end p 64
###begin p 65
###xml 141 144 <span type="species:ncbi:10116">rat</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
###xml 224 230 <span type="species:ncbi:9986">rabbit</span>
###xml 236 239 <span type="species:ncbi:9913">cow</span>
###xml 315 321 <span type="species:ncbi:9986">rabbit</span>
###xml 456 460 <span type="species:ncbi:9925">goat</span>
###xml 479 485 <span type="species:ncbi:9793">donkey</span>
###xml 539 543 <span type="species:ncbi:9925">goat</span>
###xml 554 560 <span type="species:ncbi:9913">bovine</span>
###xml 749 753 <span type="species:ncbi:9925">goat</span>
###xml 759 765 <span type="species:ncbi:9986">rabbit</span>
- Immunofluorescence on brain sections. Ten microm coronal cortex cryosections were incubated overnight at +4degreesC with biotin-conjugated rat anti-mouse CD11b monoclonal antibody (1:200; clone no. M1/70, BD Biosciences), rabbit anti-cow GFAP (1:500, Dako) or anti-subunit c of mitochondrial ATP synthase (ScMAS) rabbit serum (1:1000, a gift Pr. D. Palmer, Lincoln University, Canterbury, New-Zeland). After pre-incubation in blocking buffer (10% normal goat serum, 10% normal donkey serum in PBS for anti-CD11b and anti-GFAP; 2% normal goat serum, 5% bovine serum albumin, 0.02% saponin for anti-ScMAS) for 30 min at room temperature, bound antibodies were revealed with streptavidin Alexa Fluor(R) 488 (1:1000, Molecular Probes, anti CD11b), or goat anti-rabbit Alexa Fluor(R) 647 (1:500, Invitrogen, anti-GFAP and anti-ScMAS) for 1 hour at room temperature. Nuclei were stained with Hoechst (1:500, Sigma), sections were mounted with Fluoromount (Southern Biotech) and examined by confocal fluorescence microscopy (CD11b, 63x, LSM510, Carl Zeiss, MicroImaging, Inc.) or fluorescence microscopy (GFAP, 20x, Axiovision software, Carl Zeiss, MicroImaging, Inc.). Images were acquired from 3 to 6 randomly chosen fields.
###end p 65
###begin p 66
###xml 428 432 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Marsh1">[49]</xref>
###xml 535 539 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Saifer1">[50]</xref>
###xml 753 759 <span type="species:ncbi:9913">bovine</span>
- Lysosomal enzyme assays on brain sections. Anesthetized animals were perfused with PBS and cerebral hemispheres were separated. Tissue was homogenised in water, submitted to 10 freeze/thaw cycles and clarified by centrifugation at 13,000 rpm for 3 min. NaGlu and total ss-hexosaminidases activities were determined by fluorometric assays using 4 mM 4-methylumbelliferyl-N-acetyl-alpha-D-glucosaminide (Calbiochem) for 2 hours [49] or 1 mM 4-methylumbelliferyl-2acetamido2deoxy-alpha-D-glucopyranoside (Sigma) substrate for 5 minutes [50], respectively. One catalytic unit corresponds to the hydrolysis of 1 nmol of substrate per hour and expressed per mg of proteins in extracts. Protein concentration was determined with a BCA protein assay kit with bovine serum albumin as the standard.
###end p 66
###begin p 67
###xml 539 543 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Whitley1">[51]</xref>
- Analysis of glycosaminoglycans in brain extracts. Frozen samples were homogenized with a minimum volume of water (10% vol/weight). Defatted pellets were dried and weighed. Dried residues were digested overnight at 65degreesC with papain (0.3% w:v) in 3 ml of 100 mM sodium acetate buffer pH 5.5 containing 5 mM cysteine and 5 mM EDTA. After centrifugation, GAGs were measured in the supernatant with a dimethylmethylene blue dye binding assay. Briefly, 200 microl of the supernatant was added to 2.5 ml of dimethylmethylene blue reagent [51] and the absorbance at 535 nm was measured. Heparan sulfate was used as standard. Data (means of duplicates) were expressed as microg of GAGs per mg of dried pellet.
###end p 67
###begin p 68
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Desmaris1">[52]</xref>
- Ganglioside assay. The analysis of gangliosides was performed as has been previously described [52]. Data (mean of duplicates) were expressed as mole percentage of total gangliosides.
###end p 68
###begin title 69
Quantitative RT-PCR
###end title 69
###begin p 70
###xml 227 232 223 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12&#8211;18</sub>
###xml 1433 1437 1405 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002296-Simpson1">[53]</xref>
- Procedure. Total RNA was extracted using Trizol (Invitrogen) from approximately 300,000 cells or from 50 mg of cortex and suspended in 30 microL of water. One microgram of total RNA was used to synthesize cDNA with oligo (dT)12-18 (200 ng, Roche Applies Science, Meylan, France) and M-MLV reverse transcriptase (Superscript III, Invitrogen). Quantitative PCR was performed in a Model 7000 Sequence Detector (Applied Biosystems, Foster City, CA) with 100 ng of cDNA and the SYBR Green PCR Master Mix (according to Applied Biosystems procedures). Amplification parameters: 50degreesC for 2 minutes, 95degreesC for 10 minutes, 95degreesC for 15 seconds, 60degreesC for 1 minute. Each sample was analyzed in triplicate. Negative controls included omission of reverse transcriptase at the cDNA synthesis step and omission of the template at the PCR step. Additional controls performed for each cDNA amplification included optimization of primer concentration, assessment of amplification efficiency and detection of possible primer dimerization through analysis of dissociation curves. Ct (Cycle threshold) values were determined as the numbers of PCR cycles at which specific amplification of the target sequence occurred. Ct superior to 38 were considered as background signal. cDNA amounts were expressed as 2exp(Ct1-Ct2), in which Ct1 is a reference Ct measured for the amplification of ARPO (Acidic ribosomal phosphoprotein) cDNAs [53] and Ct2 is the Ct measured for the amplification of the examined cDNA. Samples were analyzed in triplicate.
###end p 70
###begin p 71
###xml 26 53 26 53 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCAGAGGCACCATTGAAATT-3&#8242;</named-content>
###xml 64 87 64 87 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCGCTGGCTCCCACCTT-3&#8242;</named-content>
###xml 109 136 105 132 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GAGTGACAAGCCTGTAGCCCA-3&#8242;</named-content>
###xml 147 169 143 165 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGCTGGCTCAGCCAC-3&#8242;</named-content>
###xml 188 219 183 214 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAACCAACAAGTGATATTCTCCATG-3&#8242;</named-content>
###xml 229 256 224 251 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GATCCACACTCTCCAGCTGCA-3&#8242;</named-content>
###xml 278 303 269 294 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGCAACCAAGTCTTCTCA-3&#8242;</named-content>
###xml 314 340 305 331 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCATTCAGTTCCAGGTCAGT-3&#8242;</named-content>
###xml 358 386 349 377 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACCATGCTGTGCTGTATGAGA-3&#8242;</named-content>
###xml 397 428 388 419 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTTCAATCTTTTGGTCCCTCATCA-3&#8242;</named-content>
- Primers: ARPO, forward: 5'-TCCAGAGGCACCATTGAAATT-3', reverse: 5'-TCGCTGGCTCCCACCTT-3'; TNF-alpha, forward: 5'-GAGTGACAAGCCTGTAGCCCA-3', reverse: 5'-GCGCTGGCTCAGCCAC-3'; IL-1ss, forward: 5'-CAACCAACAAGTGATATTCTCCATG-3' reverse: 5'-GATCCACACTCTCCAGCTGCA-3'; MIP1alpha, forward: 5'-CTGCAACCAAGTCTTCTCA-3', reverse: 5'-GCATTCAGTTCCAGGTCAGT-3'; GAP43, forward: 5'-CACCATGCTGTGCTGTATGAGA-3', reverse: 5'-TGTTCAATCTTTTGGTCCCTCATCA-3'.
###end p 71
###begin title 72
Supporting Information
###end title 72
###begin p 73
(0.03 MB DOC)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
(0.94 MB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
(0.36 MB DOC)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
(0.23 MB DOC)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
(1.57 MB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
###xml 259 266 <span type="species:ncbi:9606">patient</span>
We thank Pr. E. Neufeld for the gift of the MPSIIIB mice, Pr. S. Akira and Dr. M. Chignard for providing us with TLR4 and MyD88 deficient mouse strains, Pr. D. Palmer for the gift of the ScMAS antibody, Dr. R. Froissart and Dr. B. Heron for the collection of patient urines, Dr M. Piraud for help with HS oligosaccharide purification. We are grateful to S. Blanchard for excellent technical help and to H. Fsiho for help in poly[I:C] activation. This work was supported by a joint program of the Association Francaise contre les Myopathies (AFM) and the Institut Pasteur.
###end p 83
###begin title 84
References
###end title 84
###begin article-title 85
A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.
###end article-title 85
###begin article-title 86
Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
###end article-title 86
###begin article-title 87
###xml 27 32 <span type="species:ncbi:9606">human</span>
Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease.
###end article-title 87
###begin article-title 88
Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits.
###end article-title 88
###begin article-title 89
Innate immunity in amyotrophic lateral sclerosis.
###end article-title 89
###begin article-title 90
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Activation of human microglial cells by HIV-1 gp41 and Tat proteins.
###end article-title 90
###begin article-title 91
Early and progressive accumulation of reactive microglia in the Huntington disease brain.
###end article-title 91
###begin article-title 92
Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism.
###end article-title 92
###begin article-title 93
The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases.
###end article-title 93
###begin article-title 94
Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies.
###end article-title 94
###begin article-title 95
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.
###end article-title 95
###begin article-title 96
Inflammation in Alzheimer disease: driving force, bystander or beneficial response?
###end article-title 96
###begin article-title 97
Systemic infections and inflammation affect chronic neurodegeneration.
###end article-title 97
###begin article-title 98
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
###end article-title 98
###begin article-title 99
Axon degeneration mechanisms: commonality amid diversity.
###end article-title 99
###begin article-title 100
Calcium and neurodegeneration.
###end article-title 100
###begin article-title 101
The roles of intracellular protein-degradation pathways in neurodegeneration.
###end article-title 101
###begin article-title 102
A Block of Autophagy in Lysosomal Storage Disorders.
###end article-title 102
###begin article-title 103
Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.
###end article-title 103
###begin article-title 104
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
###end article-title 104
###begin article-title 105
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Chemokine-induced recruitment of genetically modified bone marrow cells into the CNS of GM1-gangliosidosis mice corrects neuronal pathology.
###end article-title 105
###begin article-title 106
###xml 43 49 <span type="species:ncbi:10090">murine</span>
Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia.
###end article-title 106
###begin article-title 107
Metachromatic leukodystrophy: consequences of sulphatide accumulation.
###end article-title 107
###begin article-title 108
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Activated microglia in cortex of mouse models of mucoploysaccharidoses I and IIIB.
###end article-title 108
###begin article-title 109
Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB.
###end article-title 109
###begin article-title 110
Neurochemical characterization of canine alpha-L-iduronidase deficiency disease.
###end article-title 110
###begin article-title 111
Secondary accumulation of gangliosides in lysosomal storage disorders.
###end article-title 111
###begin article-title 112
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase.
###end article-title 112
###begin article-title 113
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B.
###end article-title 113
###begin article-title 114
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Attenuated plasticity in neurons and astrocytes in the mouse model of Sanfilippo syndrome type B.
###end article-title 114
###begin article-title 115
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 94 116 <span type="species:ncbi:272636">adeno-associated virus</span>
Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum.
###end article-title 115
###begin article-title 116
Disease-specific markers for the mucopolysaccharidoses.
###end article-title 116
###begin article-title 117
Gangliosides trigger inflammatory responses via TLR4 in brain glia.
###end article-title 117
###begin article-title 118
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.
###end article-title 118
###begin article-title 119
Lysosomal glycosphingolipid recognition by NKT cells.
###end article-title 119
###begin article-title 120
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice.
###end article-title 120
###begin article-title 121
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
###end article-title 121
###begin article-title 122
The mucopolysaccharidoses.
###end article-title 122
###begin article-title 123
###xml 61 67 <span type="species:ncbi:10090">murine</span>
Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B.
###end article-title 123
###begin article-title 124
Breakdown of axonal synaptic vesicle precursor transport by microglial nitric oxide.
###end article-title 124
###begin article-title 125
Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport.
###end article-title 125
###begin article-title 126
Diagnosis of mucopolysaccharidoses in a clinically selected population by urinary glycosaminoglycan analysis: a study of 2,000 urine samples.
###end article-title 126
###begin article-title 127
###xml 71 76 <span type="species:ncbi:9606">human</span>
Isolation and characterization of glycosaminoglycans from atria of the human heart.
###end article-title 127
###begin article-title 128
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.
###end article-title 128
###begin article-title 129
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.
###end article-title 129
###begin article-title 130
System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.
###end article-title 130
###begin article-title 131
The molecular basis of Sanfilippo syndrome type B.
###end article-title 131
###begin article-title 132
###xml 32 54 <span type="species:ncbi:272636">adeno-associated virus</span>
Factors influencing recombinant adeno-associated virus production.
###end article-title 132
###begin article-title 133
4-Methylumbelliferyl alpha-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease.
###end article-title 133
###begin article-title 134
Automated determination of serum hexosaminidase A by pH inactivation for detection of Tay-Sachs disease heterozygotes.
###end article-title 134
###begin article-title 135
Diagnostic test for mucopolysaccharidosis. II. Rapid quantification of glycosaminoglycan in urine samples collected on a paper matrix.
###end article-title 135
###begin article-title 136
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Prevention of neuropathology in the mouse model of Hurler syndrome by AAV vector-mediated gene therapy.
###end article-title 136
###begin article-title 137
Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR.
###end article-title 137
###begin p 138
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 138
###begin p 139
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by a joint program of the Association Francaise contre les myopathies and the Institut Pasteur.
###end p 139

